Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1]

G. J. Peters; C. J. van Groeningen; G. Giaccone; J. White R.M.

doi:10.1200/JCO.2001.19.22.4267

Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1]

G. J. Peters^*
, C. J. van Groeningen
, G. Giaccone
, J. White R.M.

^*Corresponding author for this work

Amsterdam UMC - Vrije Universiteit Amsterdam

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	4267-4269
Journal	Journal of clinical oncology
Volume	19
Issue number	22
DOIs	https://doi.org/10.1200/JCO.2001.19.22.4267
Publication status	Published - 15 Nov 2001
Externally published	Yes

Access to Document

10.1200/JCO.2001.19.22.4267

Cite this

@article{3cba0ee38716415f9dc231938533e03f,

title = "Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1]",

author = "Peters, \{G. J.\} and \{van Groeningen\}, \{C. J.\} and G. Giaccone and \{White R.M.\}, J.",

year = "2001",

month = nov,

day = "15",

doi = "10.1200/JCO.2001.19.22.4267",

language = "English",

volume = "19",

pages = "4267--4269",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "22",

}

TY - JOUR

T1 - Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1]

AU - Peters, G. J.

AU - van Groeningen, C. J.

AU - Giaccone, G.

AU - White R.M., J.

PY - 2001/11/15

Y1 - 2001/11/15

UR - https://www.scopus.com/pages/publications/0035890826

UR - https://www.ncbi.nlm.nih.gov/pubmed/11709571

U2 - 10.1200/JCO.2001.19.22.4267

DO - 10.1200/JCO.2001.19.22.4267

M3 - Comment/Letter to the editor

C2 - 11709571

SN - 0732-183X

VL - 19

SP - 4267

EP - 4269

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 22

ER -

Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor [multiple letters] [1]

Access to Document

Other files and links

Cite this